Skip to main content
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.290
+0.110 (9.32%)
Nov 4, 2024, 4:00 PM EST - Market closed

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $10.20M in the quarter ending June 30, 2024, with 275.44% growth. This brings the company's revenue in the last twelve months to $118.46M, up 118.43% year-over-year. In the year 2023, Spero Therapeutics had annual revenue of $103.78M with 93.95% growth.

Revenue (ttm)
$118.46M
Revenue Growth
+118.43%
P/S Ratio
0.58
Revenue / Employee
$2,575,196
Employees
46
Market Cap
69.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023103.78M50.27M93.95%
Dec 31, 202253.51M35.25M193.10%
Dec 31, 202118.26M8.93M95.67%
Dec 31, 20209.33M-8.82M-48.59%
Dec 31, 201918.15M14.18M357.56%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
111, Inc. 2.03B
Precision BioSciences 87.64M
LENSAR 45.12M
Forian 20.37M
Verrica Pharmaceuticals 13.91M
Milestone Scientific 8.42M
InspireMD 6.57M
Entera Bio 57.00K
Revenue Rankings

SPRO News

More News